Wokadine 0.1 Solution 100 ml

Babies: It is applicable for babies. Lactating mother: It is safe. Limited studies have shown that the drug does not pass into the breastmilk and is not harmful to the baby. Pregnancy: It is unsafe in pregnancy.
Limited studies have shown that it has adverse effects on the developing baby. Seek doctor advice before using this medication. Driving: No interactions found. Alcohol: No interactions found. Liver: No interactions found. Kidney: No interactions found..

Application site reactions (burning, irritation, itching, and redness).

Wokadine solution is an antihistamine. It works by slowly releasing iodine which kills or prevents the growth of infectious microorganisms..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Try to give these medicines simultaneously each day to help you remember • Your child may feel sleepy or dizzy after each dose of bilastine syrup. If this happens, make your child sit or lie down and ask them to be careful while performing tasks that require mental focus • Avoid giving bilastine syrup with fatty meals and fruit juice as both can reduce the absorption of the medicine • Bilastine syrup can trigger constipation in your child.
Give plenty of fluids and a fibre-rich diet to your child • Do not share your child's medicines with other medicines..

• Bilastine + Acrivastine: Concurrent use of leads to increase the risk or severity of qtc prolongation • Bilastine + Adenosine: Concurrent use leads to an increase in the risk or severity of qtc prolongation • Bilastine + Ajmaline: Concurrent use of leads to increase the risk or severity of qtc prolongation • Bilastine + Alfuzosin: Concurrent leads to increase the risk or severity of qtc prolongation • Bilastine + Amantadine: Concurrent use leads to an increase in the risk or severity of qtc prolongation • Bilastine + Chlorprothixene: Concurrent use leads to an increase in the risk or severity of qtc prolongation • Bilastine + Clomipramine: Concurrent use leads to an increase in the risk or severity of qtc prolongation.